Table 2.
Demographic characteristics and history of hospitalization abroad of patients colonized or infected with CRO, Frankfurt/Main, 1.4.2012- 31.03.2013
| Total | P. aeruginosa | A. baumannii | K. pneumoniae | E. coli | Enterobacter | |
|---|---|---|---|---|---|---|
| Total | 243a | 153 | 28 | 33 | 13 | 12 |
| Age (years) (mean) | 58.9 ± 20.1 | 59.5 ± 19.7 | 53.1 ± 17.2 | 59.4 ± 19.5 | 59.2 ± 23.3 | 58,0 ± 30,7 |
| Age range (years) | 0-97 | 0-97 | 18-84 | 0-90 | 2-91 | 0-89 |
| Percentage of male patients | 66.7 | 60.1 | 82.1 | 81.8 | 61.5 | 83.3 |
| Hospitalization abroad during previous 6 months | 32 patientsb | N = 10 | N = 11 | N = 7 | N = 2 | N = 1 |
| Iran | Egypt | Egypt | Qatar | Sri Lanka | ||
| Kuwait | Brasil | Greece | India | |||
| Brasil | Ukraine | Nicaragua | ||||
| Qatar | Qatar | Italy | ||||
| India | Kosovo | India (n = 2) | ||||
| Egypt | Russia | Turkey | ||||
| Nicaragua | India | |||||
| Venezuela | Thailand | |||||
| Russia | (n = 2) | |||||
| Macedonia | Turkey | |||||
| Morocco | ||||||
| Place of residence abroad | N = 21 (8.6%) | N = 11 | N = 6 | N = 2 | N = 2 | |
| Egypt | Algeria | Egypt | India | |||
| Iran | Egypt | India | Egypt | |||
| India | Qatar | |||||
| Kuwait | Kuwait | |||||
| Macedonia | Russia (n = 2) | |||||
| Qatar (n = 2) | ||||||
| Russia | ||||||
| Saudi Arabia | ||||||
| Ukraine | ||||||
| Venezuela | ||||||
| Infection (%) | 29.7 | 24.2 | 28.6 | 30.3 | 23.1 | 50.0 |
| Carbapenemase (cases) | 32 casesc | Metallo-ß-lactamase, unspecified (n = 3) | OXA-23-like (n = 7) | OXA-23-like (n = 1) | OXA-48 (n = 4) | |
| VIM-1 (n = 1) | NDM-1 (n = 1) | OXA-48 (n = 4) | NDM-7 (n = 1) | |||
| VIM-2 (n = 3) | NDM, not further specified (n = 3) | |||||
| KPC-2 (n = 1) | ||||||
| KPC-3 (n = 1) |
aincluding C. koseri, E. sakazakii. 1 K. oxytoca, P mirabilis.
bincluding 1 patient, C. koseri Libya.
cincluding OXA-48 (n = 1) from C. koseri; NDM1/6 (n = 1) from K. oxytoca.